- Home
- DXCM vs ARES Comparison
DXCM vs ARES Comparison
Compare DXCM & ARES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- ARES
- Stock Information
- Founded
- DXCM 1999
- ARES 1997
- Country
- DXCM United States
- ARES United States
- Employees
- DXCM N/A
- ARES N/A
- Industry
- DXCM Medical/Dental Instruments
- ARES Investment Managers
- Sector
- DXCM Health Care
- ARES Finance
- Exchange
- DXCM Nasdaq
- ARES Nasdaq
- Market Cap
- DXCM 28.0B
- ARES 35.7B
- IPO Year
- DXCM 2005
- ARES 2014
- Fundamental
- Price
- DXCM $80.24
- ARES $181.06
- Analyst Decision
- DXCM Buy
- ARES Buy
- Analyst Count
- DXCM 17
- ARES 14
- Target Price
- DXCM $98.00
- ARES $166.00
- AVG Volume (30 Days)
- DXCM 3.4M
- ARES 1.2M
- Earning Date
- DXCM 02-06-2025
- ARES 02-06-2025
- Dividend Yield
- DXCM N/A
- ARES 2.06%
- EPS Growth
- DXCM 83.21
- ARES 0.39
- EPS
- DXCM 1.67
- ARES 2.19
- Revenue
- DXCM $3,954,000,000.00
- ARES $3,679,765,000.00
- Revenue This Year
- DXCM $13.10
- ARES $0.31
- Revenue Next Year
- DXCM $14.74
- ARES $34.12
- P/E Ratio
- DXCM $48.12
- ARES $82.86
- Revenue Growth
- DXCM 16.19
- ARES 4.67
- 52 Week Low
- DXCM $62.34
- ARES $112.83
- 52 Week High
- DXCM $142.00
- ARES $185.06
- Technical
- Relative Strength Index (RSI)
- DXCM 58.78
- ARES 57.80
- Support Level
- DXCM $74.50
- ARES $169.01
- Resistance Level
- DXCM $81.51
- ARES $185.06
- Average True Range (ATR)
- DXCM 2.57
- ARES 4.73
- MACD
- DXCM -0.10
- ARES -0.41
- Stochastic Oscillator
- DXCM 81.88
- ARES 75.08
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About ARES Ares Management Corporation
Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets and Secondaries Group. Its Credit Group generates maximum revenue, and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate and infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure and credit.